🚨Pediatric Neurologist Whistleblower Claims Big Pharma Suppresses Autism-Reversing Drug
February 18, 2025
In a shocking revelation that could potentially reshape the landscape of autism treatment, a pediatric neurologist has come forward, alleging that Big Pharma is hiding a generic drug capable of reversing symptoms associated with autism.
This whistleblower, whose identity remains undisclosed for fear of professional retribution, claims that this drug has been known to the pharmaceutical industry for years but has been deliberately kept from the public eye.
According to the whistleblower, the drug in question, Leucovorin, which is already on the market for other uses, has shown remarkable results in reducing autism symptoms when administered to children.
The neurologist asserts that this medication helps normalize certain brain functions that are typically disrupted in individuals with autism spectrum disorders.
Leucovorin is derived from folic acid—also known as vitamin B9—a crucial nutrient for DNA synthesis and brain development.
While folate, its natural form, is found in foods like leafy vegetables, beans, and eggs, some children with autism may have a hidden deficiency due to a biological blockade that prevents folate from reaching the brain.
Leucovorin helps bypass this blockage, potentially unlocking critical developmental functions like speech and cognitive abilities.
The allegations have reignited debates about the ethical practices within the pharmaceutical industry, particularly concerning the suppression of treatments that do not align with the profit-driven motives of large corporations.
Critics argue that the focus on patented, high-cost medications over potentially effective generics could be depriving millions of an affordable treatment option.
For Mason Connor, a young boy from Arizona diagnosed with autism at two-and-a-half years old, this discovery changed everything. Despite years of speech therapy and treatments, Mason remained nonverbal.
That was until his parents met Dr. Frye at Rossignol Medical Center in Arizona, who suggested they try Leucovorin, a drug typically used to protect red blood cells in cancer patients undergoing chemotherapy.
Just three days after starting the $2.50 pills of Leucovorin, Mason spoke his first words at age three.
Dr. Frye told CBS News: “[Leucovorin] could really have a substantial impact on a very good percentage of children with autism.”
According to the CDC, about one in 36 children in the U.S.—nearly two million—have autism. Many are diagnosed by age five, though testing can begin as early as age two.
Research from the National Institutes of Health suggests that nearly 70% of autistic children have folate receptor autoantibodies, which attack healthy cells and block folate absorption in the brain.
This deficiency may contribute to common symptoms like language delays and behavioral issues.
Dr. Frye’s studies provide compelling evidence of Leucovorin’s effectiveness. In one study, 44 autistic children with these autoantibodies received 50 milligrams of Leucovorin daily for four months.
The results were staggering. Every child experienced improvements in language, behavior, mood, attention, and aggression. Another 2018 study from his team confirmed these findings, reporting significant gains in language skills and reductions in irritability, hyperactivity, and lethargy.
Despite its potential, Leucovorin is only FDA-approved for chemotherapy patients and certain types of anemia, though doctors can prescribe it off-label for autism.
This claim follows a pattern of similar whistleblower stories involving Big Pharma. Over recent years, several reports have highlighted potential cures or treatments for conditions like cancer, ADHD, and even the effects of vaccinations, which have been alleged to be intentionally obscured by the industry.
For instance, there have been discussions around ivermectin for cancer treatment and how gut bacteria might be more effective than mood-regulating drugs for certain pediatric disorders, further fueling public distrust in pharmaceutical giants.
Moreover, the narrative of suppression by Big Pharma aligns with broader concerns about transparency and patient welfare, especially in the context of recent trends where public trust in health institutions has been waning, as seen in various discussions on social media platforms like X.
The whistleblower's testimony mentions that while the drug has been used in clinical settings with positive outcomes, no large-scale studies have been initiated or funded by major pharmaceutical companies.
This lack of research, according to the neurologist, is not due to a lack of potential but rather a lack of financial incentive, as generics do not offer the lucrative profits of newly patented drugs.
The implications of these allegations are profound.
If true, they could lead to significant changes in how treatments for autism are developed, funded, and made accessible.
It might also prompt regulatory bodies like the FDA to re-evaluate the approval and promotion of generic drugs for off-label uses that could benefit public health.
😎👍PLEASE help support our work and projects 🙏here https://tip.joshwho.net or paypal Please🙏 and thank you🫶 https://paypal.com/cgi-bin/webscr?cmd=_donations&business=josh.who.inc@gmail.com&item_name=Tip&cy_code=USD&bn=PP%2dDonationsBF
From these conclusions one can only assume Big Pharmakia uses its sorcery to harm us. Opposite of what they are supposed to do.